BioCorRx (BICX) Equity Ratio (2016 - 2025)
Historic Equity Ratio for BioCorRx (BICX) over the last 16 years, with Q3 2025 value amounting to 1.79.
- BioCorRx's Equity Ratio rose 9040.29% to 1.79 in Q3 2025 from the same period last year, while for Sep 2025 it was 1.79, marking a year-over-year increase of 9040.29%. This contributed to the annual value of 32.01 for FY2024, which is 22508.93% down from last year.
- BioCorRx's Equity Ratio amounted to 1.79 in Q3 2025, which was up 9040.29% from 1.95 recorded in Q2 2025.
- BioCorRx's 5-year Equity Ratio high stood at 25.59 for Q4 2023, and its period low was 34.24 during Q1 2024.
- Over the past 5 years, BioCorRx's median Equity Ratio value was 8.49 (recorded in 2021), while the average stood at 9.44.
- In the last 5 years, BioCorRx's Equity Ratio crashed by 37524.41% in 2022 and then skyrocketed by 33920.47% in 2023.
- Over the past 5 years, BioCorRx's Equity Ratio (Quarter) stood at 8.49 in 2021, then dropped by 26.02% to 10.7 in 2022, then surged by 339.2% to 25.59 in 2023, then plummeted by 225.09% to 32.01 in 2024, then skyrocketed by 94.41% to 1.79 in 2025.
- Its last three reported values are 1.79 in Q3 2025, 1.95 for Q2 2025, and 1.74 during Q1 2025.